Streetbeat News

Price Targets

CAPR

HC Wainwright & Co. analyst Joseph Pantginis maintains a 'Buy' rating on Capricor Therapeutics (NASDAQ:CAPR) and raises the price target from $18 to $40.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:14 am

ADAG

HC Wainwright & Co. analyst Arthur He has reiterated a 'Buy' rating on Adagene (NASDAQ:ADAG) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:12 am

CABA

HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Cabaletta Bio (NASDAQ:CABA) and maintained a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:10 am

PEP

Barclays analyst Lauren Lieberman maintains an Overweight rating on PepsiCo (NASDAQ:PEP) but has lowered the price target from $198 to $179.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:09 am

AVDL

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Avadel Pharmaceuticals (NASDAQ:AVDL) and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:07 am

LII

Barclays analyst Julian Mitchell has maintained an Equal-Weight rating on Lennox Intl (NYSE:LII) and raised the price target from $350 to $400.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:07 am

PLRX

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Pliant Therapeutics (NASDAQ:PLRX) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:05 am

TROX

Barclays analyst Michael Leithead has maintained an Overweight rating on Tronox Holdings (NYSE:TROX) but lowered the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:05 am

KRO

Barclays analyst Michael Leithead has maintained an Underweight rating on Kronos Worldwide (NYSE:KRO) and lowered the price target from $7 to $6.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:03 am

FVRR

UBS analyst Kunal Madhukar has initiated coverage on Fiverr Intl (NYSE:FVRR) with a Buy rating and a price target of $33.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 10:02 am